1. MDM2 Antagonist Nutlin-3 Stimulates Global DNA Hydroxymethylation by Enhancing p53–TET1 Signaling Axis
    Danni Wu et al, 2023, ACS Chemical Biology CrossRef
  2. Immunity drives TET1 regulation in cancer through NF-κB
    Evelyne Collignon et al, 2018, Science Advances CrossRef
  3. Dissecting bipolar disorder complexity through epigenomic approach
    B Ludwig et al, 2016, Molecular Psychiatry CrossRef
  4. Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells
    Matteo Forloni et al, 2016, Cell Reports CrossRef
  5. Ten-eleven translocation 1 functions as a mediator of SOD3 expression in human lung cancer A549 cells
    Tetsuro Kamiya et al, 2017, Free Radical Research CrossRef
  6. miR-29b is an indicator of prognosis in breast cancer patients
    YOSHIAKI SHINDEN et al, 2015, Molecular and Clinical Oncology CrossRef
  7. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
    Jiangxia Fan et al, 2018, Clinical Epigenetics CrossRef
  8. Overexpression of Sirt6 is a novel biomarker of malignant human colon carcinoma
    Chang‐hui Geng et al, 2018, Journal of Cellular Biochemistry CrossRef
  9. Targeted DNA Demethylation: Vectors, Effectors and Perspectives
    Naohiro Yano et al, 2023, Biomedicines CrossRef
  10. miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1
    Jin Liu et al, 2018, International Journal of Oncology CrossRef
  11. Hydroxyurea promotes TET1 expression and induces apoptosis in osteosarcoma cells
    Songsong Teng et al, 2019, Bioscience Reports CrossRef
  12. Δ9-Tetrahydrocannabinol stimulation of estrogen receptor-positive MCF-7 breast cancer cell migration: Interfering interaction with the estrogenic milieu
    Shuso Takeda et al, 2023, Forensic Toxicology CrossRef
  13. Misregulation of DNA Methylation Regulators in Cancer
    Joyce J. Thompson et al, 2017, DNA and Histone Methylation as Cancer Targets CrossRef
  14. TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets
    Eric Genaro Salmerón-Bárcenas et al, 2023, International Journal of Molecular Sciences CrossRef
  15. Downregulation of TET1 Promotes Bladder Cancer Cell Proliferation and Invasion by Reducing DNA Hydroxymethylation of AJAP1
    Yi-lin Yan et al, 2020, Frontiers in Oncology CrossRef
  16. Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis
    Jiao Song et al, 2016, Bioorganic & Medicinal Chemistry Letters CrossRef
  17. TET1 suppresses colon cancer proliferation by impairing β‐catenin signal pathway
    Hailong Guo et al, 2019, Journal of Cellular Biochemistry CrossRef
  18. miR-646/TET1 mediated demethylation of IRX1 promoter upregulates HIST2H2BE and promotes the progression of invasive ductal carcinoma
    Baoxia He et al, 2021, Genomics CrossRef
  19. Retracted: Forkhead box protein k1 recruits TET1 to act as a tumor suppressor and is associated with MRI detection
    Taotao Sun et al, 2016, Japanese Journal of Clinical Oncology CrossRef
  20. The effect of sodium butyrate and cisplatin on expression of EMT markers
    Alena Mrkvicova et al, 2019, PLOS ONE CrossRef